Gyeonggi-do, South Korea

Yang Soon Lee

This inventor holds 1 USPTO granted patent. Top assignee: Abl Bio Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yang Soon Lee. Retrieved from https://idiyas.com/inventor/yang-soon-lee-pv4tk2ia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yang Soon Lee: Innovator in Bispecific Antibodies

Introduction

Yang Soon Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. His innovative work has the potential to advance therapeutic options for various diseases.

Latest Patents

Yang Soon Lee holds a patent for "ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF." This patent represents a significant advancement in the treatment of conditions that may benefit from bispecific antibody therapies. He has successfully secured 1 patent in this area, showcasing his expertise and dedication to innovation.

Career Highlights

Currently, Yang Soon Lee is associated with Abl Bio Inc., a company known for its focus on developing innovative biopharmaceuticals. His role at Abl Bio Inc. allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

Yang Soon Lee has worked alongside notable colleagues, including Kyung Jin Park and Sae Yi Lim. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of bispecific antibodies.

Conclusion

In summary, Yang Soon Lee is a dedicated inventor whose work in bispecific antibodies is paving the way for new therapeutic approaches. His contributions to the field are invaluable, and his ongoing efforts at Abl Bio Inc. continue to inspire innovation in biomedicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…